Your browser doesn't support javascript.
loading
Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features.
Yoo, Kwai Han; Yoon, Dok Hyun; Kang, Hye Jin; Lee, Won Sik; Kim, Kihyun; Kim, Jin Seok; Kim, Jeong-A; Kim, Sung-Hyun; Kwak, Jae-Yong; Kim, Yang Soo; Min, Chang-Ki; Lee, Je-Jung; Yoon, Sung-Soo; Suh, Cheolwon; Baz, Rachid; Lee, Jae Hoon.
Afiliación
  • Yoo KH; Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
  • Yoon DH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kang HJ; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
  • Lee WS; Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • Kim K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim JS; Yonsei University College of Medicine, Severance Hospital, Seoul, Korea.
  • Kim JA; St. Vincent Hospital College of Medicine, The Catholic University of Korea, Suwon, Korea.
  • Kim SH; Dong-A Medical Center, Dong-A University College of Medicine, Busan, Korea.
  • Kwak JY; Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea.
  • Kim YS; Kosin University Gospel Hospital, Busan, Korea.
  • Min CK; Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
  • Lee JJ; Chonnam University Hwasun Hospital, Hwasun, Korea.
  • Yoon SS; Seoul National University Hospital, Seoul, Korea.
  • Suh C; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Baz R; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Lee JH; Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea. Electronic address: jhlee@gilhospital.com.
Curr Probl Cancer ; 46(1): 100788, 2022 02.
Article en En | MEDLINE | ID: mdl-34454742

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lenalidomida / Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Curr Probl Cancer Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lenalidomida / Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Aged / Humans Idioma: En Revista: Curr Probl Cancer Año: 2022 Tipo del documento: Article
...